AbbVie Inc (ABBV)
NYSE · Healthcare · Drug Manufacturers - General
AbbVie Inc is a Healthcare company with a market capitalization of $447.62B, a trailing P/E ratio of 123.6, and a dividend yield of 2.77%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 29, 2026 | $2.65 | $2.67 | -0.8% |
| Q4 2025 | February 4, 2026 | $2.71 | $2.65 | +2.3% |
| Q3 2025 | October 31, 2025 | $1.86 | $1.78 | +4.5% |
| Q2 2025 | July 31, 2025 | $2.97 | $2.91 | +2.1% |
| Q1 2025 | April 25, 2025 | $2.46 | $2.40 | +2.5% |
| Q4 2024 | January 31, 2025 | $2.16 | $2.12 | +1.9% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is AbbVie Inc's market cap?
As of June 29, 2026, AbbVie Inc (ABBV) has a market capitalization of $447.62B.
What is AbbVie Inc's P/E ratio?
AbbVie Inc trades at a trailing price-to-earnings (P/E) ratio of 123.6. Its forward P/E is 17.8.
Does AbbVie Inc pay a dividend?
Yes — AbbVie Inc pays a dividend yielding 2.77%, an annual payout of $6.74 per share.
What sector is ABBV in?
AbbVie Inc is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was AbbVie Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), AbbVie Inc reported revenue of $61.16B and net income of $4.23B.
Ask your own questions about ABBV
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.